196 related articles for article (PubMed ID: 38111019)
1. Bronchoalveolar cytokine profile differentiates Pulmonary Langerhans cell histiocytosis patients from other smoking-related interstitial lung diseases.
Barril S; Acebo P; Millan-Billi P; Luque A; Sibila O; Tarín C; Tazi A; Castillo D; Hortelano S
Respir Res; 2023 Dec; 24(1):320. PubMed ID: 38111019
[TBL] [Abstract][Full Text] [Related]
2. Essential role of osteopontin in smoking-related interstitial lung diseases.
Prasse A; Stahl M; Schulz G; Kayser G; Wang L; Ask K; Yalcintepe J; Kirschbaum A; Bargagli E; Zissel G; Kolb M; Müller-Quernheim J; Weiss JM; Renkl AC
Am J Pathol; 2009 May; 174(5):1683-91. PubMed ID: 19359522
[TBL] [Abstract][Full Text] [Related]
3. Utility of bronchoscopy in pulmonary Langerhans cell histiocytosis.
Baqir M; Vassallo R; Maldonado F; Yi ES; Ryu JH
J Bronchology Interv Pulmonol; 2013 Oct; 20(4):309-12. PubMed ID: 24162113
[TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar lavage for the diagnosis of Pulmonary Langerhans cell histiocytosis.
Lommatzsch M; Bratke K; Stoll P; Mülleneisen N; Prall F; Bier A; Virchow JC
Respir Med; 2016 Oct; 119():168-174. PubMed ID: 27692140
[TBL] [Abstract][Full Text] [Related]
5. Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases.
Bergantini L; d'Alessandro M; Cameli P; Perrone A; Cekorja B; Boncompagni B; Mazzei MA; Sestini P; Bargagli E
Eur J Intern Med; 2021 Jul; 89():76-80. PubMed ID: 33931268
[TBL] [Abstract][Full Text] [Related]
6. BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience.
Domagała-Kulawik J
Diagn Cytopathol; 2008 Dec; 36(12):909-15. PubMed ID: 18855907
[TBL] [Abstract][Full Text] [Related]
7. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
8. Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter?
Domagała-Kulawik J; Skirecki T; Maskey-Warzechowska M; Grubek-Jaworska H; Chazan R
Inflammation; 2012 Jun; 35(3):803-9. PubMed ID: 21882075
[TBL] [Abstract][Full Text] [Related]
9. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
[TBL] [Abstract][Full Text] [Related]
10. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases.
Efared B; Ebang-Atsame G; Rabiou S; Diarra AS; Tahiri L; Hammas N; Smahi M; Amara B; Benjelloun MC; Serraj M; Chbani L; El Fatemi H
J Negat Results Biomed; 2017 Mar; 16(1):4. PubMed ID: 28245857
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary langerhans cell histiocytosis (histiocytosis X) on bronchoalveolar lavage: a report of 2 cases.
Zeppa P; Cozzolino I; Russo M; Cataldo PT; Vetrani A; Palombini L
Acta Cytol; 2007; 51(3):480-2. PubMed ID: 17536561
[TBL] [Abstract][Full Text] [Related]
13. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
[TBL] [Abstract][Full Text] [Related]
14. Smoking-related interstitial lung disease.
Hagmeyer L; Randerath W
Dtsch Arztebl Int; 2015 Jan; 112(4):43-50. PubMed ID: 25797422
[TBL] [Abstract][Full Text] [Related]
15. Clinical analysis for 15 patients with pulmonary Langerhans cell histiocytosis and literature review.
Zhang L; Ouyang R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):334-343. PubMed ID: 35545326
[TBL] [Abstract][Full Text] [Related]
16. Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.
Kass DJ; Nouraie M; Glassberg MK; Ramreddy N; Fernandez K; Harlow L; Zhang Y; Chen J; Kerr GS; Reimold AM; England BR; Mikuls TR; Gibson KF; Dellaripa PF; Rosas IO; Oddis CV; Ascherman DP
Arthritis Rheumatol; 2020 Mar; 72(3):409-419. PubMed ID: 31532072
[TBL] [Abstract][Full Text] [Related]
17. Adult pulmonary Langerhans' cell histiocytosis.
Tazi A
Eur Respir J; 2006 Jun; 27(6):1272-85. PubMed ID: 16772390
[TBL] [Abstract][Full Text] [Related]
18. Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease.
Kamionek M; Ahmadi Moghaddam P; Sakhdari A; Kovach AE; Welch M; Meng X; Dresser K; Tomaszewicz K; Cosar EF; Mark EJ; Fraire AE; Hutchinson L
Histopathology; 2016 Sep; 69(3):499-509. PubMed ID: 26915300
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Langerhans cell histiocytosis: a comprehensive analysis of 40 patients and literature review.
Elia D; Torre O; Cassandro R; Caminati A; Harari S
Eur J Intern Med; 2015 Jun; 26(5):351-6. PubMed ID: 25899682
[TBL] [Abstract][Full Text] [Related]
20. Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
Patolia S; Tamae Kakazu M; Chami HA; Chua A; Diaz-Mendoza J; Duggal A; Jenkins AR; Knight SL; Raghu G; Wilson KC
Ann Am Thorac Soc; 2020 Nov; 17(11):1455-1467. PubMed ID: 32757946
[No Abstract] [Full Text] [Related]
[Next] [New Search]
